Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
95
datasets available to search
ShareScore release 0.9.0
Dataset results
95 results for “Lymphoma cancer”
PROACT: Can we Prevent Chemotherapy-related Heart Damage in Patients With Breast Cancer and Lymphoma?
ClinicalTrials.gov study NCT03265574. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
SNX-5422 to Treat Solid Tumor Cancers and Lymphomas
ClinicalTrials.gov study NCT00644072. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Phase II Cancer Vaccine Trial for Patients With Follicular Lymphoma
ClinicalTrials.gov study NCT01926639. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT04009317. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue
ClinicalTrials.gov study NCT03747757. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I/II Trial of Alectinib and Bevacizumab in Patients With Advanced, Anaplastic Lymphoma Kinase (ALK)-Positive, Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT02521051. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Expanded Access Study of Alectinib for Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC) After Disease Progression on or Intolerance to Prior ALK Tyrosin
ClinicalTrials.gov study NCT02271139. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Anaplastic Lymphoma Kinase (ALK)-Positive Non-small Cell Lung Cancer (NSCLC) Post-alectinib Treatment Patterns
ClinicalTrials.gov study NCT04351334. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia)
ClinicalTrials.gov study NCT04849416. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Repeat Intranodal Injection of Memgen's Cancer Vaccine, Ad-ISF35, in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
ClinicalTrials.gov study NCT00849524. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma
ClinicalTrials.gov study NCT01185548. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or
ClinicalTrials.gov study NCT04541017. IPD Sharing: YES. Countries: 1. Publications: 0.
Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas
ClinicalTrials.gov study NCT02763254. IPD Sharing: NO. Countries: 1. Publications: 0.
Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated
ClinicalTrials.gov study NCT02921191. IPD Sharing: YES. Countries: 0. Publications: 2.
Studying An Investigational Drug Crizotinib (PF-02341066) In Non Non-Small Cell Lung Cancer Tumors That Are Positive For Anaplastic Lymphoma Kinase (ALK)
ClinicalTrials.gov study NCT01121588. IPD Sharing: NO. Countries: 7. Publications: 0.
Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer
ClinicalTrials.gov study NCT01499303. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study to Determine Progression-free Survival (PFS) and Evaluate Participant Experience for Participants With Metastatic Anaplastic Lymphoma Kinase-positive (ALK+) Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03546894. IPD Sharing: YES. Countries: 1. Publications: 0.
Context-defined cancer co-dependency mapping identifies a functional interplay between PRC2 and MLL-MEN1 complex in lymphoma
GEO Series GSE183487. Homo sapiens. 77 samples. Type: Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing; Other.
Gene regulation changes driven by wild type and cancer-associated mutant variants of Myc as B-cells convert to Lymphoma-like cells
GEO Series GSE122602. Mus musculus. 63 samples. Type: Expression profiling by high throughput sequencing.
Genetic variants associated with development of colorectal cancer, type 1 diabetes, Hodgkin lymphoma and Diffuse large B-cell lymphoma
GEO Series GSE156411. Homo sapiens. 72 samples. Type: Genome variation profiling by SNP array.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.